New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
09:10 EDTELGXEndologix announces enrollment of first patient in EVAS FORWARD-IDE trial
Endologix announced that the first patient was treated in the EVAS FORWARD-IDE clinical trial, the company's pivotal clinical trial to evaluate the safety and effectiveness of the Nellix EndoVascular Aneurysm Sealing System for the endovascular repair of infrarenal abdominal aortic aneurysms.
News For ELGX From The Last 14 Days
Check below for free stories on ELGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
10:00 EDTELGXOn The Fly: Analyst Upgrade Summary
CBOE Holdings (CBOE) upgraded to Outperform from Market Perform at Raymond James... Silver Bay Realty (SBY) upgraded to Overweight from Neutral at JPMorgan... U.S. Steel (X) upgraded to Outperform from Underperform at Credit Suisse... Endologix (ELGX) upgraded to Buy from Neutral at BTIG... Texas Roadhouse (TXRH) upgraded to Overweight from Equal Weight at Stephens... WPX Energy (WPX) upgraded to Outperform from Sector Perform at Howard Weil... Nomura (NMR) upgraded to Outperform from Neutral at Credit Suisse.
07:29 EDTELGXEndologix upgraded to Buy from Neutral at BTIG
Subscribe for More Information
August 24, 2014
21:54 EDTELGXPiper Jaffray to hold a bus tour
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use